PerpEquities

Equity · Healthcare

Is Abbott Laboratories (ABT) tradable as a perp? Not yet

Abbott Laboratories is a global healthcare company developing and selling pharmaceuticals, diagnostics, nutritional products, and medical devices.

Not yet listed on any perp exchange

No perpetual-futures venue lists ABT yet. We track it continuously; as soon as the first listing appears, this page becomes a full market page. Until then: fundamentals below and tradable alternatives.

Similar stocks already tradable as perps
GILDNVOPFEAMGNISRGVRTX

Price chart

Interactive TradingView chart

TradingView symbol NYSE:ABT

Loads TradingView's third-party widget (about 1 MB) on demand.

Auto: underlying reference priceOpen in TradingView

Company data

Company fundamentals

Updated 2h ago
Market cap
$177.5B
Updated 2h ago
Revenue
$46.6B
Trailing 12 months
Revenue growth
+13%
Next fiscal year
Profit margin
+11.6%
P/E
33.0
Peer P/E 26.6
Free cash flow
$8.7B
Trailing 12 months
More metrics
Net income
$5.4B
Trailing 12 months
P/S
3.8
Peer P/E
26.6
Similar listed perps
Revenue estimate
$50.3B
Next fiscal year
Earnings
2026-10-21
Revenue est. $13B · Updated 2h ago
Dividend
$0.63
2026-10-15

Fundamental detail

Annual + quarterly
Latest revenue$44.3B
Net margin+14.7%
Free cash flow$7.4B
Net debt$6.5B
2020$34.6B
2021$43.1B
2022$43.7B
2023$40.1B
2024$42B
2025$44.3B
PeriodRevenueGrowthNet incomeFCF
2020$34.6B+8%$4.5B$5.7B
2021$43.1B+24%$7.1B$8.6B
2022$43.7B+1%$6.9B$7.8B
2023$40.1B-8%$5.7B$5.1B
2024$42B+5%$13.4B$6.4B
2025$44.3B+6%$6.5B$7.4B
PeriodGross marginOperating marginNet marginROEROA
2020+50.2%+15.3%+13.0%+13.7%+6.2%
2021+53.9%+21.4%+16.4%+19.8%+9.4%
2022+51.1%+19.2%+15.9%+18.9%+9.3%
2023+50.0%+16.0%+14.3%+14.8%+7.8%
2024+50.8%+16.3%+31.9%+28.1%+16.5%
2025+55.5%+18.2%+14.7%+12.5%+7.5%
PeriodCashDebtNet debtCurrent ratio
2020$6.8B$19.9B$13.1B1.72
2021$9.8B$19.3B$9.5B1.85
2022$9.9B$17.9B$8.1B1.63
2023$6.9B$15.9B$9B1.64
2024$7.6B$15.3B$7.7B1.67
2025$8.5B$15.1B$6.5B1.58
PeriodMarket capEnterprise valueP/SP/E
2020$194.1B$207.2B5.643.4
2021$249.8B$259.3B5.835.5
2022$192.5B$200.5B4.427.9
2023$190.9B$199.8B4.833.4
2024$195.9B$203.5B4.714.7
2025$218.9B$225.4B4.933.5
Q3 2024$10.6B
Q4 2024$11B
Q1 2025$10.4B
Q2 2025$11.1B
Q3 2025$11.4B
Q4 2025$11.5B
Q1 2026$11.2B
Q2 2026$12.6B
PeriodRevenueGrowthNet incomeFCF
Q3 2024$10.6B+5%$1.6B$2.1B
Q4 2024$11B+7%$9.2B$2.1B
Q1 2025$10.4B+4%$1.3B$933M
Q2 2025$11.1B+7%$1.8B$1.5B
Q3 2025$11.4B+7%$1.6B$2.3B
Q4 2025$11.5B+4%$1.8B$2.6B
Q1 2026$11.2B+8%$1.1B$916M
Q2 2026$12.6B+13%$928M$2.9B
PeriodGross marginOperating marginNet marginROEROA
Q3 2024+51.0%+17.1%+15.5%+4.1%+2.2%
Q4 2024+51.0%+18.1%+84.1%+19.4%+11.3%
Q1 2025+52.6%+16.3%+12.8%+2.7%+1.6%
Q2 2025+56.4%+18.4%+16.0%+3.5%+2.1%
Q3 2025+55.7%+18.1%+14.5%+3.2%+2.0%
Q4 2025+57.0%+19.6%+15.5%+3.4%+2.0%
Q1 2026+56.3%+16.5%+9.6%+2.1%+1.0%
Q2 2026+58.0%+14.2%+7.4%+1.8%+0.8%
PeriodCashDebtNet debtCurrent ratio
Q3 2024$7.6B$15B$7.4B1.60
Q4 2024$7.6B$15.3B$7.7B1.67
Q1 2025$6.5B$13.2B$6.7B1.78
Q2 2025$7B$13.4B$6.5B1.82
Q3 2025$7.5B$12.9B$5.4B1.70
Q4 2025$8.5B$15.1B$6.5B1.58
Q1 2026$6.8B$34B$27.2B1.39
Q2 2026$5.1B$32.6B$27.5B1.38
PeriodMarket capEnterprise valueP/SP/E
Q3 2024$197.7B$205.2B18.630.0
Q4 2024$195.9B$203.5B17.85.3
Q1 2025$231.8B$238.5B22.443.7
Q2 2025$236.7B$243.2B21.233.3
Q3 2025$234.3B$239.7B20.635.6
Q4 2025$218.9B$225.4B19.130.7
Q1 2026$179.4B$206.6B16.141.4
Q2 2026$158.2B$185.7B12.642.8

Refreshed 2h ago

Charts: revenue, profit, cash flow & valuation
Revenue$12.6BQ2 2026
$3.1B$6.3B$9.4B$12.6BQ3 2023: $10.1BQ4 2023: $10.2BQ1 2024: $10BQ2 2024: $10.4BQ3 2024: $10.6BQ4 2024: $11BQ1 2025: $10.4BQ2 2025: $11.1BQ3 2025: $11.4BQ4 2025: $11.5BQ1 2026: $11.2BQ2 2026: $12.6BQ3 2023Q2 2026
Net income$928MQ2 2026
$2.3B$4.6B$6.9B$9.2BQ3 2023: $1.4BQ4 2023: $1.6BQ1 2024: $1.2BQ2 2024: $1.3BQ3 2024: $1.6BQ4 2024: $9.2BQ1 2025: $1.3BQ2 2025: $1.8BQ3 2025: $1.6BQ4 2025: $1.8BQ1 2026: $1.1BQ2 2026: $928MQ3 2023Q2 2026
EBITDA$1.8BQ2 2026
$773M$1.5B$2.3B$3.1BQ3 2023: $2.6BQ4 2023: $2.8BQ1 2024: $2.4BQ2 2024: $2.6BQ3 2024: $2.9BQ4 2024: $3BQ1 2025: $2.7BQ2 2025: $3BQ3 2025: $3.1BQ4 2025: $2.8BQ1 2026: $2.2BQ2 2026: $1.8BQ3 2023Q2 2026
Free cash flow$2.9BQ2 2026
$721.8M$1.4B$2.2B$2.9BQ3 2023: $1.3BQ4 2023: $2.3BQ1 2024: $627MQ2 2024: $1.4BQ3 2024: $2.1BQ4 2024: $2.1BQ1 2025: $933MQ2 2025: $1.5BQ3 2025: $2.3BQ4 2025: $2.6BQ1 2026: $916MQ2 2026: $2.9BQ3 2023Q2 2026
EPS$0.53Q2 2026
$1.32$2.64$3.95$5.27Q3 2023: $0.82Q4 2023: $0.91Q1 2024: $0.7Q2 2024: $0.74Q3 2024: $0.94Q4 2024: $5.27Q1 2025: $0.76Q2 2025: $1.01Q3 2025: $0.94Q4 2025: $1.02Q1 2026: $0.62Q2 2026: $0.53Q3 2023Q2 2026
Cash / Debt$5.1BQ2 2026
$8.5B$17B$25.5B$34BQ3 2023 · Cash: $6.7BQ3 2023 · Debt: $15.5BQ4 2023 · Cash: $6.9BQ4 2023 · Debt: $15.9BQ1 2024 · Cash: $6.3BQ1 2024 · Debt: $14.6BQ2 2024 · Cash: $7BQ2 2024 · Debt: $14.8BQ3 2024 · Cash: $7.6BQ3 2024 · Debt: $15BQ4 2024 · Cash: $7.6BQ4 2024 · Debt: $15.3BQ1 2025 · Cash: $6.5BQ1 2025 · Debt: $13.2BQ2 2025 · Cash: $7BQ2 2025 · Debt: $13.4BQ3 2025 · Cash: $7.5BQ3 2025 · Debt: $12.9BQ4 2025 · Cash: $8.5BQ4 2025 · Debt: $15.1BQ1 2026 · Cash: $6.8BQ1 2026 · Debt: $34BQ2 2026 · Cash: $5.1BQ2 2026 · Debt: $32.6BQ3 2023Q2 2026
CashDebt
Profitability+58.0%Q2 2026
+21.0%+42.0%+63.1%+84.1%Q3 2023 · Gross margin: +49.6%Q4 2023 · Gross margin: +51.3%Q1 2024 · Gross margin: +50.4%Q2 2024 · Gross margin: +51.1%Q3 2024 · Gross margin: +51.0%Q4 2024 · Gross margin: +51.0%Q1 2025 · Gross margin: +52.6%Q2 2025 · Gross margin: +56.4%Q3 2025 · Gross margin: +55.7%Q4 2025 · Gross margin: +57.0%Q1 2026 · Gross margin: +56.3%Q2 2026 · Gross margin: +58.0%Q3 2023 · Operating margin: +16.5%Q4 2023 · Operating margin: +18.2%Q1 2024 · Operating margin: +13.9%Q2 2024 · Operating margin: +16.2%Q3 2024 · Operating margin: +17.1%Q4 2024 · Operating margin: +18.1%Q1 2025 · Operating margin: +16.3%Q2 2025 · Operating margin: +18.4%Q3 2025 · Operating margin: +18.1%Q4 2025 · Operating margin: +19.6%Q1 2026 · Operating margin: +16.5%Q2 2026 · Operating margin: +14.2%Q3 2023 · Net margin: +14.2%Q4 2023 · Net margin: +15.6%Q1 2024 · Net margin: +12.3%Q2 2024 · Net margin: +12.5%Q3 2024 · Net margin: +15.5%Q4 2024 · Net margin: +84.1%Q1 2025 · Net margin: +12.8%Q2 2025 · Net margin: +16.0%Q3 2025 · Net margin: +14.5%Q4 2025 · Net margin: +15.5%Q1 2026 · Net margin: +9.6%Q2 2026 · Net margin: +7.4%Q3 2023Q2 2026
Gross marginOperating marginNet margin
Revenue growth+13.0%Q2 2026
+3.3%+6.5%+9.8%+13.0%Q3 2024: +4.9%Q4 2024: +7.2%Q1 2025: +4.0%Q2 2025: +7.4%Q3 2025: +6.9%Q4 2025: +4.4%Q1 2026: +7.8%Q2 2026: +13.0%Q3 2023Q2 2026
Shares outstanding1.7BQ2 2026
437.8M875.5M1.3B1.8BQ3 2023: 1.7BQ4 2023: 1.7BQ1 2024: 1.8BQ2 2024: 1.8BQ3 2024: 1.7BQ4 2024: 1.7BQ1 2025: 1.7BQ2 2025: 1.8BQ3 2025: 1.7BQ4 2025: 1.7BQ1 2026: 1.7BQ2 2026: 1.7BQ3 2023Q2 2026
Valuation42.8Q2 2026
10.921.932.843.7Q3 2023 · P/E: 29.2Q4 2023 · P/E: 29.9Q1 2024 · P/E: 39.5Q2 2024 · P/E: 34.4Q3 2024 · P/E: 30.0Q4 2024 · P/E: 5.3Q1 2025 · P/E: 43.7Q2 2025 · P/E: 33.3Q3 2025 · P/E: 35.6Q4 2025 · P/E: 30.7Q1 2026 · P/E: 41.4Q2 2026 · P/E: 42.8Q3 2023 · P/S: 16.6Q4 2023 · P/S: 18.6Q1 2024 · P/S: 19.5Q2 2024 · P/S: 17.2Q3 2024 · P/S: 18.6Q4 2024 · P/S: 17.8Q1 2025 · P/S: 22.4Q2 2025 · P/S: 21.2Q3 2025 · P/S: 20.6Q4 2025 · P/S: 19.1Q1 2026 · P/S: 16.1Q2 2026 · P/S: 12.6Q3 2023Q2 2026
P/EP/S
Revenue$44.3B2025
$11.1B$22.2B$33.2B$44.3B2018: $30.6B2019: $31.9B2020: $34.6B2021: $43.1B2022: $43.7B2023: $40.1B2024: $42B2025: $44.3B20182025
Net income$6.5B2025
$3.4B$6.7B$10.1B$13.4B2018: $2.4B2019: $3.7B2020: $4.5B2021: $7.1B2022: $6.9B2023: $5.7B2024: $13.4B2025: $6.5B20182025
EBITDA$11.6B2025
$3B$6.1B$9.1B$12.2B2018: $6.9B2019: $7.9B2020: $9B2021: $12.2B2022: $11.9B2023: $10.6B2024: $10.8B2025: $11.6B20182025
Free cash flow$7.4B2025
$2.2B$4.3B$6.5B$8.6B2018: $4.9B2019: $4.5B2020: $5.7B2021: $8.6B2022: $7.8B2023: $5.1B2024: $6.4B2025: $7.4B20182025
EPS$3.722025
$1.91$3.82$5.73$7.642018: $1.342019: $2.062020: $2.52021: $3.942022: $3.912023: $3.272024: $7.642025: $3.7220182025
Cash / Debt$8.5B2025
$5B$9.9B$14.9B$19.9B2018 · Cash: $3.8B2018 · Debt: $19.6B2019 · Cash: $3.9B2019 · Debt: $19.1B2020 · Cash: $6.8B2020 · Debt: $19.9B2021 · Cash: $9.8B2021 · Debt: $19.3B2022 · Cash: $9.9B2022 · Debt: $17.9B2023 · Cash: $6.9B2023 · Debt: $15.9B2024 · Cash: $7.6B2024 · Debt: $15.3B2025 · Cash: $8.5B2025 · Debt: $15.1B20182025
CashDebt
Profitability+55.5%2025
+13.9%+27.8%+41.6%+55.5%2018 · Gross margin: +51.7%2019 · Gross margin: +52.3%2020 · Gross margin: +50.2%2021 · Gross margin: +53.9%2022 · Gross margin: +51.1%2023 · Gross margin: +50.0%2024 · Gross margin: +50.8%2025 · Gross margin: +55.5%2018 · Operating margin: +12.6%2019 · Operating margin: +14.4%2020 · Operating margin: +15.3%2021 · Operating margin: +21.4%2022 · Operating margin: +19.2%2023 · Operating margin: +16.0%2024 · Operating margin: +16.3%2025 · Operating margin: +18.2%2018 · Net margin: +7.7%2019 · Net margin: +11.6%2020 · Net margin: +13.0%2021 · Net margin: +16.4%2022 · Net margin: +15.9%2023 · Net margin: +14.3%2024 · Net margin: +31.9%2025 · Net margin: +14.7%20182025
Gross marginOperating marginNet margin
Revenue growth+5.7%2025
0.0%+8.2%+16.3%+24.5%2019: +4.3%2020: +8.5%2021: +24.5%2022: +1.3%2023: -8.1%2024: +4.6%2025: +5.7%20182025
Shares outstanding1.7B2025
447.3M894.5M1.3B1.8B2018: 1.8B2019: 1.8B2020: 1.8B2021: 1.8B2022: 1.8B2023: 1.7B2024: 1.7B2025: 1.7B20182025
Valuation33.52025
13.426.840.253.62018 · P/E: 53.62019 · P/E: 42.02020 · P/E: 43.42021 · P/E: 35.52022 · P/E: 27.92023 · P/E: 33.42024 · P/E: 14.72025 · P/E: 33.52018 · P/S: 4.22019 · P/S: 4.82020 · P/S: 5.62021 · P/S: 5.82022 · P/S: 4.42023 · P/S: 4.82024 · P/S: 4.72025 · P/S: 4.920182025
P/EP/S

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 20265.52$50.3B+13%18
FY 20276.06$54.7B+23%18
FY 20286.72$58.5B+32%12
FY 20297.45$62.9B+42%9
FY 20308.28$67.2B+52%5
Q1 20271.28$12.8B+15%8

Company events

6
2026-10-21EarningsActual - / Estimate 1.43-
2026-10-15Dividend$0.63-
2026-07-16EarningsActual 1.31 / Estimate 1.28Beat
2026-07-15Dividend$0.63-
2026-04-16EarningsActual 1.15 / Estimate 1.14Beat
2026-04-15Dividend$0.63-

Peer comparison

Similar listed perps
NameMarket capP/SP/EProfit marginVenues
GILD$186.4B6.1-57.7-10.6%7NVO$192B3.810.7+35.3%14PFE$157.3B2.536.5+6.8%3AMGN$208.1B5.523.8+22.9%7ISRG$139B12.644.4+28.4%8VRTX$129B10.229.3+34.9%3TMO$242.1B5.235.0+15.1%2NVS$266.8B4.821.2+23.1%2

Analyst track record

How the analysts covering ABT have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings151433
Analysts2932
Buy / hold / sell143 / 8 / 0398 / 35 / 0
Upgrades / downgrades / initiations1 / 1 / 22 / 2 / 6
Price targets hit / missed3 / 130 (2%)3 / 398 (1%)
Avg. return after a rating (TipRanks)-22.1%-23.0%
Best / worst call+14.8% / -39.5%+14.8% / -39.5%

After buy calls on this stock: median 21-day move +1.0% vs S&P 500 -1.2% (n = 387)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Shagun Singh ChadhaRBC Capital81% hit rate on this stock · 16 targets measuredBuytarget $130Jul 16, 2026
  2. Larry BiegelsenWells Fargo75% hit rate on this stock · 56 targets measuredBuytarget $112Sep 8, 2026
  3. Lee HambrightBernstein75% hit rate on this stock · 8 targets measuredBuytarget $125Jan 23, 2026

Latest ratings

DateAnalystCallTarget
Sep 14, 2026Josh JenningsTD CowenBuyReiterated$135article ↗
Sep 10, 2026Joanne WuenschCitiBuyMaintained$125article ↗
Sep 10, 2026Joanne WuenschCitiBuyMaintained$125
Sep 8, 2026Larry BiegelsenWells FargoBuyMaintained$112article ↗
Sep 1, 2026Robbie MarcusJ.P. MorganBuyMaintained–article ↗
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$90.00$100$110$120$130$140$150Oct 25 · Buy 19 · Hold 3 · Sell 0Oct 25Nov 25 · Buy 20 · Hold 3 · Sell 0Dec 25 · Buy 20 · Hold 3 · Sell 0Dec 25Jan 26 · Buy 20 · Hold 3 · Sell 0Feb 26 · Buy 20 · Hold 3 · Sell 0Feb 26Mar 26 · Buy 19 · Hold 3 · Sell 0Apr 26 · Buy 19 · Hold 4 · Sell 0Apr 26May 26 · Buy 18 · Hold 4 · Sell 0Jun 26 · Buy 20 · Hold 4 · Sell 0Jun 26Jul 26 · Buy 22 · Hold 4 · Sell 0Aug 26 · Buy 23 · Hold 3 · Sell 0Aug 26Sep 26 · Buy 23 · Hold 3 · Sell 0Oct 25 · avg. target $146Nov 25 · avg. target $146Dec 25 · avg. target $146Jan 26 · avg. target $140Feb 26 · avg. target $139Mar 26 · avg. target $138Apr 26 · avg. target $122May 26 · avg. target $120Jun 26 · avg. target $118Jul 26 · avg. target $120Aug 26 · avg. target $122Sep 26 · avg. target $122Oct 25 · month-end close $124Nov 25 · month-end close $129Dec 25 · month-end close $125Jan 26 · month-end close $109Feb 26 · month-end close $116Mar 26 · month-end close $103Apr 26 · month-end close $90.79May 26 · month-end close $85.60Jun 26 · month-end close $90.74Jul 26 · month-end close $106Aug 26 · month-end close $110Sep 26 · month-end close $102

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data via FMP · computed Sep 18, 2026 · 151 ratings